chrX-100646647-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_014467.3(SRPX2):​c.82+243C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0202 in 112,017 control chromosomes in the GnomAD database, including 36 homozygotes. There are 614 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.020 ( 36 hom., 614 hem., cov: 23)

Consequence

SRPX2
NM_014467.3 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.524

Publications

0 publications found
Variant links:
Genes affected
SRPX2 (HGNC:30668): (sushi repeat containing protein X-linked 2) This gene encodes a secreted protein that contains three sushi repeat motifs. The encoded protein may play a role in the development of speech and language centers in the brain. This protein may also be involved in angiogenesis. Mutations in this gene are the cause of bilateral perisylvian polymicrogyria, rolandic epilepsy, speech dyspraxia and cognitive disability. [provided by RefSeq, May 2010]
SRPX2 Gene-Disease associations (from GenCC):
  • rolandic epilepsy-speech dyspraxia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • polymicrogyria, bilateral perisylvian, X-linked
    Inheritance: XL Classification: LIMITED Submitted by: G2P
  • rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked
    Inheritance: XL Classification: LIMITED, NO_KNOWN Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • epilepsy
    Inheritance: XL Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-100646647-C-T is Benign according to our data. Variant chrX-100646647-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 677499.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0202 (2264/112017) while in subpopulation NFE AF = 0.0298 (1587/53187). AF 95% confidence interval is 0.0286. There are 36 homozygotes in GnomAd4. There are 614 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 2264 XL,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014467.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SRPX2
NM_014467.3
MANE Select
c.82+243C>T
intron
N/ANP_055282.1O60687

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SRPX2
ENST00000373004.5
TSL:1 MANE Select
c.82+243C>T
intron
N/AENSP00000362095.3O60687
SRPX2
ENST00000638458.1
TSL:5
c.82+243C>T
intron
N/AENSP00000492168.1A0A1W2PR88
SRPX2
ENST00000640889.1
TSL:5
c.82+243C>T
intron
N/AENSP00000492571.1A0A1W2PRB1

Frequencies

GnomAD3 genomes
AF:
0.0202
AC:
2266
AN:
111964
Hom.:
37
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00503
Gnomad AMI
AF:
0.117
Gnomad AMR
AF:
0.0218
Gnomad ASJ
AF:
0.0378
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00298
Gnomad FIN
AF:
0.00709
Gnomad MID
AF:
0.0596
Gnomad NFE
AF:
0.0298
Gnomad OTH
AF:
0.0324
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0202
AC:
2264
AN:
112017
Hom.:
36
Cov.:
23
AF XY:
0.0180
AC XY:
614
AN XY:
34197
show subpopulations
African (AFR)
AF:
0.00501
AC:
155
AN:
30909
American (AMR)
AF:
0.0218
AC:
230
AN:
10555
Ashkenazi Jewish (ASJ)
AF:
0.0378
AC:
100
AN:
2648
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3549
South Asian (SAS)
AF:
0.00337
AC:
9
AN:
2673
European-Finnish (FIN)
AF:
0.00709
AC:
43
AN:
6066
Middle Eastern (MID)
AF:
0.0514
AC:
11
AN:
214
European-Non Finnish (NFE)
AF:
0.0298
AC:
1587
AN:
53187
Other (OTH)
AF:
0.0320
AC:
49
AN:
1531
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
77
154
232
309
386
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0241
Hom.:
144
Bravo
AF:
0.0211

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.1
DANN
Benign
0.61
PhyloP100
-0.52
PromoterAI
-0.020
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56259360; hg19: chrX-99901644; API